Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR.
Vigón L, Vázquez-Morón S, Berenguer J, González-García J, Jiménez-Sousa MÁ, Guardiola JM, Crespo M, de Los Santos I, Von Wichmann MA, Carrero A, Yélamos MB, Gómez J, Resino S, Martínez I; GESIDA 3603b Cohort Study Group. Vigón L, et al. Among authors: yelamos mb. Sci Rep. 2019 Aug 21;9(1):12163. doi: 10.1038/s41598-019-48592-5. Sci Rep. 2019. PMID: 31434968 Free PMC article.
Negative impact of HIV infection on broad-spectrum anti-HCV neutralizing antibody titers in HCV-infected patients with advanced HCV-related cirrhosis.
Sepúlveda-Crespo D, Yélamos MB, Díez C, Gómez J, Hontañón V, Torresano-Felipe F, Berenguer J, González-García J, Ibañez-Samaniego L, Llop E, Olveira A, Martínez J, Resino S, Martínez I. Sepúlveda-Crespo D, et al. Among authors: yelamos mb. Biomed Pharmacother. 2022 Jun;150:113024. doi: 10.1016/j.biopha.2022.113024. Epub 2022 Apr 25. Biomed Pharmacother. 2022. PMID: 35483197 Free article.
Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study.
Sepúlveda-Crespo D, Volpi C, Amigot-Sánchez R, Yélamos MB, Díez C, Gómez J, Hontañón V, Berenguer J, González-García J, Martín-Escolano R, Resino S, Martínez I. Sepúlveda-Crespo D, et al. Among authors: yelamos mb. Pharmaceuticals (Basel). 2024 Aug 30;17(9):1152. doi: 10.3390/ph17091152. Pharmaceuticals (Basel). 2024. PMID: 39338314 Free PMC article.